Diploma PLC (LON:DPLM) Insider Purchases £19,740 in Stock

Diploma PLC (LON:DPLM) insider Ian El-Mokadem bought 500 shares of the firm’s stock in a transaction that occurred on Monday, March 24th. The stock was acquired at an average cost of GBX 3,948 ($51.11) per share, with a total value of £19,740 ($25,556.71).

Diploma Trading Up 0.8 %

LON DPLM opened at GBX 4,000 ($51.79) on Friday. The company has a market cap of £5.34 billion, a PE ratio of 45.98, a PEG ratio of 2.82 and a beta of 0.75. Diploma PLC has a 12 month low of GBX 3,468 ($44.90) and a 12 month high of GBX 4,808 ($62.25). The stock has a 50 day moving average of GBX 4,373.28 and a 200-day moving average of GBX 4,373.96. The company has a current ratio of 2.17, a quick ratio of 0.80 and a debt-to-equity ratio of 62.17.

Diploma Increases Dividend

The company also recently declared a dividend, which was paid on Friday, January 31st. Shareholders of record on Thursday, January 16th were paid a GBX 42 ($0.54) dividend. The ex-dividend date of this dividend was Thursday, January 16th. This represents a yield of 0.93%. This is a boost from Diploma’s previous dividend of $17.30. Diploma’s dividend payout ratio (DPR) is currently 65.52%.

Wall Street Analyst Weigh In

Separately, JPMorgan Chase & Co. increased their price objective on shares of Diploma from GBX 4,370 ($56.58) to GBX 4,420 ($57.22) and gave the stock a “neutral” rating in a research note on Tuesday, January 14th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of GBX 4,567.50 ($59.13).

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.